Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05996237 · ClinicalTrials.gov registry record
Older Adults' Readiness to Stop Prescribed Medications
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 108
- Enrollment target
NCT05996237: Completed study, sponsored by University of Pittsburgh.
NCT05996237 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 108 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05996237 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 108 participants
- Enrollment target
Study Summary
Polypharmacy, regular use of 5+ prescribed medications, is common among older adults and potentially harmful. Patients differ in their concern about medications, comfort in raising questions about them, and trust and confidence in physician judgment. This pilot observational research will determine older adults' readiness to "deprescribe," that is, stop prescribed medications under physician guidance.
Primary Outcome
Self-report measure (Linsky 2020): range 1-5; high scores = greater readiness to deprescribe; mean (SD) in VA sample 2.99 (0.80)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2023-09-21 |
| Est. Completion | 2024-12-31 |
What the finished NCT05996237 record still lists
NCT05996237 is an observational study that tracks outcomes without assigning an intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT05996237 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05996237 about?
NCT05996237 is a clinical study titled "Older Adults' Readiness to Stop Prescribed Medications". Polypharmacy, regular use of 5+ prescribed medications, is common among older adults and potentially harmful. Patients differ in their concern about medications, comfort in raising questions about them, and trust and confidence in physician judgment. This pilot observational research will determine ...
What is the current status of trial NCT05996237?
This trial is currently completed. The enrollment target is 108 participants. The study started on 2023-09-21. Estimated completion is 2024-12-31.
Who is sponsoring clinical trial NCT05996237?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI